Advanced search×

[Effect of vitamin beverages on vitamin sufficiency of the workers of Pskov Hydroelectric Power-Plant].

T V Spiricheva, O A Vrezhesinskaia, N A Beketova, O G Pereverzeva, O V Kosheleva, L A Kharitonchik, V M Kodentsova, A V Iudina, and V B Spirichev

Vopr Pitan 79(4):55-62 (2010) PMID 20968008

The research of influence of vitamin complexes in the form of a drink or kissel on vitamin sufficiency of working persons has been carried out. Long inclusion (6,5 months) in a diet of vitamin drinks containing about 80% from recommended daily consumption of vitamins, was accompanied by trustworthy improvement of vitamins C and B6 sufficiency and prevention of seasonal deterioration of beta-carotene status. As initially surveyed have been well provided with vitamins A and E, their blood serum level increase had not occurred.

Version: za2963e q8za2 q8zb9 q8zcc q8zda q8zea q8zf7 q8zg1

Similar articles you may find interesting…

  1. Matrix metalloproteinase, vitamin A and methylprednisolone effects on experimentally induced amyloid arthropathy.
    A Sevimli, A Yağcı, and A Bülbül

    Biotech Histochem (2013) PMID 23647009

    We evaluated the role of some matrix metalloproteinases (MMPs) in enhancing the effect of vitamin A and the inhibiting effect of methylprednisolone on amyloid arthropathy in brown layer chicks. We used 100 one-day-old Isa brown layer chicks. The chicks were allocated to one of four groups as follows...
  2. Prophylactic effects of methyl-3-O-methyl gallate against sodium fluoride-induced oxidative stress in erythrocytes in vivo.
    Seyed Mohammad Nabavi, Solomon Habtemariam, and Ali Mohammad Latifi

    J Pharm Pharmacol 65(6):868-73 (2013) PMID 23647680

    The purpose of this study was to demonstrate the effect of methyl-3-O-methyl gallate (M3OMG), a rare polyphenolic natural product with a potent in-vitro antioxidant effect, against sodium fluoride (NaF)-induced oxidative stress in rat erythrocytes in vivo. Male Wistar...
  3. Use of new oral anticoagulants in antiphospholipid syndrome.
    Deepa Jayakody Arachchillage and Hannah Cohen

    Curr Rheumatol Rep 15(6):331 (2013) PMID 23649961

    We discuss clinical and laboratory aspects of NOAC. These agents have been approved for several therapeutic indications based on phase III prospective randomised controlled clinical trials using warfarin at a target INR of 2.5 (i.e. range 2.0-3.0) as the comparator. However these trials may not be d...